The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Factors associated with survival in a contemporary adult sickle cell disease cohort
Open accessAbstract
In this study, the relationship of clinical differences among patients with sickle cell disease (SCD) was examined to understand the major contributors to early mortality in a contemporary cohort. Survival data were obtained for 542 adult subjects who were enrolled since 2002 at three university hospitals in the southeast United States. Subjects were followed up for a median of 9.3 years. At enrollment, clinical parameters were collected, including hemoglobin (Hb) genotype, baseline laboratory values, comorbidities, and medication usage. Levels of soluble adhesion molecules were measured for a subset of 87 subjects. The relationship of clinical characteristics to survival was determined using regression analysis. Median age at enrollment was 32 years. Median survival was 61 years for all subjects. Median survival for Hb SS and Sβ 0 was 58 years and for Hb SC and Sβ+was 66 years. Elevated white blood count, lower estimated glomerular filtration rate, proteinuria, frequency of pain crises, pulmonary hypertension, cerebrovascular events, seizures, stroke, sVCAM‐1, and short‐acting narcotics use were significantly associated with decreased survival. Forty‐two percent of subjects were on hydroxyurea therapy, which was not associated with survival. SCD continues to reduce life expectancy for affected individuals, particularly those with Hb Sβ 0 and SS. Not only were comorbidities individually associated with decreased survival but also an additive effect was observed, thus, those with a greater number of negative endpoints had worse survival (P < 0.0001). The association of higher sVCAM‐1 levels with decreased survival suggests that targeted therapies to reduce endothelial damage and inflammation may also be beneficial. Am. J. Hematol. 89:530–535, 2014. © 2014 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320 · cited 7×
“in subjects with Hb SS and 60–68 years in subjects with Hb SC [6].”
BackgroundResultInfluentialPulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035477 · Cited by 1,325
Steinberg, M. H., Barton, F., Castro, O., Pegelow, C. H., Ballas, S. K., Kutlar, A., Orringer, E., Bellevue, R., Olivieri, N., Eckman, J., et al. (2003) · JAMA · doi:10.1001/jama.289.13.1645 · Cited by 931
Self-citationCirculating Activated Endothelial Cells in Sickle Cell Anemia
Solovey, A., Lin, Y., Browne, P., Choong, S., Wayner, E., & Hebbel, R. P. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372203 · Cited by 628
Outcome of Sickle Cell Anemia: A 4-Decade Observational Study of 1056 Patients
Powars, D. R., Chan, L. S., Hiti, A., Ramicone, E., & Johnson, C. (2005) · Medicine · doi:10.1097/01.md.0000189089.45003.52 · Cited by 558
Fetal hemoglobin in sickle cell anemia
Akinsheye, I., Alsultan, A., Solovieff, N., Ngo, D., Baldwin, C. T., Sebastiani, P., Chui, D. H. K., & Steinberg, M. H. (2011) · Blood · doi:10.1182/blood-2011-03-325258 · Cited by 553
A Hemodynamic Study of Pulmonary Hypertension in Sickle Cell Disease
Parent, F., Bachir, D., Inamo, J., Lionnet, F., Driss, F., Loko, G., Habibi, A., Bennani, S., Savale, L., Adnot, S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1005565 · Cited by 512
Primary role for adherent leukocytes in sickle cell vascular occlusion: A new paradigm
Turhan, A., Weiss, L. A., Mohandas, N., Coller, B. S., & Frenette, P. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052522799 · Cited by 489
The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: a 17.5 year follow-up
Steinberg, M. H., McCarthy, W. F., Castro, O., Ballas, S. K., Armstrong, F. D., Smith, W., Ataga, K., Swerdlow, P., Kutlar, A., DeCastro, L., et al. (2010) · American Journal of Hematology · doi:10.1002/ajh.21699 · Cited by 486
Self-citationMortality in Sickle Cell Disease
(1994) · New England Journal of Medicine · doi:10.1056/nejm199410133311515 · Cited by 459
Allogeneic Hematopoietic Stem-Cell Transplantation for Sickle Cell Disease
Hsieh, M. M., Kang, E. M., Fitzhugh, C. D., Link, M. B., Bolan, C. D., Kurlander, R., Childs, R. W., Rodgers, G. P., Powell, J. D., & Tisdale, J. F. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904971 · Cited by 455
The cost of health care for children and adults with sickle cell disease
Kauf, T. L., Coates, T. D., Huazhi, L., Mody‐Patel, N., & Hartzema, A. G. (2009) · American Journal of Hematology · doi:10.1002/ajh.21408 · Cited by 388
Survival of children with sickle cell disease
Quinn, C. T., Rogers, Z. R., & Buchanan, G. R. (2004) · Blood · doi:10.1182/blood-2003-11-3758 · Cited by 377
LEIKIN, S. L., Gallagher, D. M., Kinney, T. R., Sloane, D., Klug, P., & RIDA, W. N. (1989) · PubMed · Cited by 361
Mortality in Children and Adolescents With Sickle Cell Disease
Leikin, S. L., Gallagher, D., Kinney, T. R., Sloane, D., Klug, P., & Rida, W. (1989) · Pediatrics · doi:10.1542/peds.84.3.500 · Cited by 320
Health related quality of life in sickle cell patients: The PiSCES project
McClish, D. K., Penberthy, L. T., Bovbjerg, V. E., Roberts, J. D., Aisiku, I. P., Levenson, J. L., Roseff, S. D., & Smith, W. R. (2005) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-3-50 · Cited by 298
Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease
Fitzhugh, C. D., Lauder, N., Jonassaint, J. C., Telen, M. J., Zhao, X., Wright, E. C., Gilliam, F. R., & De Castro, L. M. (2010) · American Journal of Hematology · doi:10.1002/ajh.21569 · Cited by 224
Self-citationKato, G. J., Martyr, S., Blackwelder, W. C., Nichols, J. S., Coles, W. A., Hunter, L. A., Brennan, M., Hazen, S. L., & Gladwin, M. T. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05701.x · Cited by 207
Sickle reticulocytes adhere to VCAM-1
Gee, B., & Platt, O. (1995) · Blood · doi:10.1182/blood.v85.1.268.bloodjournal851268 · Cited by 188
Minniti, C. P., Sable, C., Campbell, A., Rana, S., Ensing, G., Dham, N., Onyekwere, O., Nouraie, M., Kato, G. J., Gladwin, M. T., et al. (2009) · Haematologica · doi:10.3324/haematol.13812 · Cited by 186
Fadlon, E., Vordermeier, S., Pearson, T. C., Mire-Sluis, A. R., Dumonde, D. C., Phillips, J., Fishlock, K., & Alun Brown, K. (1998) · Blood · doi:10.1182/blood.v91.1.266 · Cited by 164
Styles, L. A., Lubin, B. H., Vichinsky, E. P., Lawrence, S., Hua, M., Test, S. T., & Kuypers, F. A. (1997) · Blood · doi:10.1182/blood.v89.7.2554 · Cited by 155
Zennadi, R., Hines, P. C., Castro, L. M. D., Cartron, J., Parise, L. V., & Telen, M. J. (2004) · Blood · doi:10.1182/blood-2004-01-0042 · Cited by 153
Self-citationEpinephrine-induced activation of LW-mediated sickle cell adhesion and vaso-occlusion in vivo
Zennadi, R., Moeller, B. J., Whalen, E. J., Batchvarova, M., Xu, K., Shan, S., Delahunty, M. D., Dewhirst, M. W., & Telen, M. J. (2007) · Blood · doi:10.1182/blood-2006-11-056101 · Cited by 121
Self-citationLevey, A. S., Berg, R. L., Gassman, J., Hall, P. M., & Walker, W. G. (1989) · PubMed · Cited by 115
Okpala, I. E., Daniel, Y., Haynes, R., Odoemene, D., & Goldman, J. M. (2002) · European Journal Of Haematology · doi:10.1034/j.1600-0609.2002.02775.x · Cited by 102
Brun, M., Bourdoulous, S., Couraud, P., Élion, J., Krishnamoorthy, R., & Lapouméroulie, C. (2003) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500176 · Cited by 87
Afenyi‐Annan, A., Kail, M. E., Combs, M. R., Orringer, E. P., Ashley‐Koch, A. E., & Telen, M. J. (2008) · Transfusion · doi:10.1111/j.1537-2995.2007.01622.x · Cited by 84
Self-citationActivation of Vascular Endothelial Cell Adhesion Molecule Expression by Sickle Blood Cells
Brown, M. D., Wick, T. M., & Eckman, J. R. (2001) · Fetal and Pediatric Pathology · doi:10.1080/15513810109168817 · Cited by 72
Self-citationRole of Adhesion Molecules and Vascular Endothelium in the Pathogenesis of Sickle Cell Disease
Telen, M. J. (2007) · Hematology · doi:10.1182/asheducation-2007.1.84 · Cited by 66
Self-citationEffects of hydroxyurea on the membrane of erythrocytes and platelets in sickle cell anemia.
Covas, D. T., Ângulo, I. L., Palma, P. V. B., & Zago, M. A. (2004) · PubMed · Cited by 65
National trends in the mortality of children with sickle cell disease, 1968 through 1992.
Davis, H., Schoendorf, K. C., Gergen, P. J., et al. (1997) · American Journal of Public Health · doi:10.2105/ajph.87.8.1317 · Cited by 59
Kaul, D. K., Liu, X.-D., Zhang, X., Mankelow, T. J., Parsons, S. F., Spring, F., An, X., Mohandas, N., Anstee, D. J., & Chasis, J. A. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00639.2005 · Cited by 53
Adhesion molecules and hydroxyurea in the pathophysiology of sickle cell disease
Johnson, C., & Telen, M. J. (2008) · Haematologica · doi:10.3324/haematol.12734 · Cited by 50
Self-citationAdherent leukocytes capture sickle erythrocytes in an in vitro flow model of vaso‐occlusion
Finnegan, E. M., Turhan, A., Golan, D. E., & Barabino, G. A. (2006) · American Journal of Hematology · doi:10.1002/ajh.20819 · Cited by 48
Cited by
Rees, D. C., Williams, T. N., & Gladwin, M. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61029-x · Cited by 2,504
Kato, G. J., Piel, F. B., Reid, C. D., Gaston, M. H., Ohene-Frempong, K., Krishnamurti, L., Smith, W. R., Panepinto, J. A., Weatherall, D. J., Costa, F. F., et al. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.10 · Cited by 1,501
Ware, R. E., de Montalembert, M., Tshilolo, L., & Abboud, M. R. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30193-9 · Cited by 977
Sickle cell disease: renal manifestations and mechanisms
Nath, K. A., & Hebbel, R. P. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.8 · Cited by 369
Central nervous system complications and management in sickle cell disease
DeBaun, M. R., & Kirkham, F. J. (2016) · Blood · doi:10.1182/blood-2015-09-618579 · Cited by 263
Metadata
- Authors
- Elmariah, H., Garrett, M. E., De Castro, L. M., Jonassaint, J. C., Ataga, K. I., Eckman, J. R., Ashley‐Koch, A. E., & Telen, M. J.
- Venue
- American Journal of Hematology
- Publisher
- Wiley
- Published
- 2014-02-21
- Volume
- 89
- Issue
- 5
- Pages
- 530-535
- ISSN
- 0361-8609 (ISSN-L)
- 1096-8652
- OpenAlex
- W1590229730
- Cited by
- 300
- References
- 35
- FWCI
- 12.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.